Status:
COMPLETED
HIV and Hepatitis Care Coordination in Methadone Treatment
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Hepatitis, Viral, Human
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized clinical trial will examine the effectiveness of a strategy of HIV and Hepatitis Care Coordination (HCC) consisting of testing, education, counseling and vaccination for methadone main...
Detailed Description
In the HCC model, HIV and hepatitis screening, and HAV and HBV vaccination will be done on site and participants receive on site theory-based HIV and hepatitis education, counseling, and case manageme...
Eligibility Criteria
Inclusion
- \>=18 years of age
- be able to provide informed consent
- agree to participate in hepatitis/HIV intervention
- expect to be available to participate in the study for the entire duration of the study
- HCV negative, of unknown HCV status, or have not received any previous medical care for HCV
Exclusion
- have already had a formal hepatitis C evaluation
- are obtaining medical care for hepatitis C
- not interested in obtaining medical care for hepatitis
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
489 Patients enrolled
Trial Details
Trial ID
NCT00608192
Start Date
January 1 2008
End Date
June 1 2011
Last Update
January 16 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco General Hospital Opiate Treatment Outpatient Program
San Francisco, California, United States, 94110
2
Beth Israel Medical Center Methadone Maintenance Program
New York, New York, United States, 10003